1 Department of Medicine, The University of Chicago , Chicago, Illinois.
Thyroid. 2013 Dec;23(12):1638-43. doi: 10.1089/thy.2013.0174. Epub 2013 Sep 13.
Resistance to thyroid hormone (RTH) is a rare condition usually diagnosed in patients with classic thyroid function tests (TFTs) of elevated thyroid hormone levels with nonsuppressed TSH. The presence of autoimmune thyroid disease (AITD) can confound the clinical diagnosis of RTH. A family was evaluated because several members had elevated TSH and normal or low serum T4 concentrations with AITD. While these individuals were initially reported to have RTH, they were found to have a normal thyroid hormone receptor beta (THRB) gene sequence, and three other asymptomatic family members were found to harbor the variant TRβ G339S.
The THRB gene was sequenced in 19 members of a large Mexican/Aztec family. In vitro expression of the mutant TRβ protein was performed, as well as computer modeling of the variant compared to known mutations in the flanking codons.
Investigation of an individual with AITD who was incorrectly diagnosed with RTH led to the fortuitous discovery of a THRB gene variant (G339S) in the proposita's father, paternal aunt, and cousin. This variant was not detected in analysis of 124 unrelated alleles. All individuals harboring G339S had normal TFTs. Normal in vitro expression and function of G339S and molecular modeling predicted that this variant would not have an effect on the hypothalamic-pituitary-thyroid axis as determined by thyroid hormone binding in vitro and thyroid function tests in vivo, despite profound effects seen in mutations in the adjacent codons 338 and 340.
We report an individual with normal TFTs and AITD harboring a novel THRB gene variant. In addition to illustrating the importance of accurate diagnosis of thyroid disease so that proper treatment and counseling can be given, TRβ codon 339 is not essential for normal TRβ function.
甲状腺激素抵抗(RTH)是一种罕见的疾病,通常在甲状腺激素水平升高且 TSH 未被抑制的经典甲状腺功能测试(TFTs)的患者中诊断。自身免疫性甲状腺疾病(AITD)的存在可能会混淆 RTH 的临床诊断。一个家族接受了评估,因为一些成员患有 AITD,同时伴有 TSH 升高和正常或低血清 T4 浓度。虽然这些个体最初被报道患有 RTH,但他们的甲状腺激素受体 β(THRB)基因序列正常,并且发现另外 3 名无症状的家族成员携带变体 TRβ G339S。
对一个大型墨西哥/阿兹特克家族的 19 名成员进行了 THRB 基因测序。对突变的 TRβ 蛋白进行了体外表达,并对变体与侧翼密码子中的已知突变进行了计算机建模。
对一名患有 AITD 且被错误诊断为 RTH 的个体进行调查,偶然发现该患者的父亲、姑父和表弟携带 THRB 基因变体(G339S)。在对 124 个无关等位基因的分析中未检测到该变体。所有携带 G339S 的个体均具有正常的 TFTs。G339S 的正常体外表达和功能以及分子建模预测,尽管在相邻密码子 338 和 340 中的突变会产生深远的影响,但该变体不会对体外甲状腺激素结合和体内甲状腺功能测试确定的下丘脑-垂体-甲状腺轴产生影响。
我们报告了一名患有正常 TFTs 和 AITD 的个体携带一种新的 THRB 基因变体。除了说明了准确诊断甲状腺疾病的重要性,以便进行适当的治疗和咨询外,TRβ 密码子 339 对于正常的 TRβ 功能并非必需。